Cancer Drug Parity Act of 2025 requires equal cost-sharing for oral and administered anticancer drugs.

The Cancer Drug Parity Act of 2025 amends the Employee Retirement Income Security Act of 1974 to mandate that group health plans provide cost-sharing for oral anticancer drugs on terms no less favorable than those for anticancer medications administered by a health care provider. This applies to medications prescribed for killing, slowing, or preventing the growth of cancerous cells. The Act prohibits plans from increasing out-of-pocket costs or applying more restrictive limitations on oral medications.

Cancer Drug Parity Act of 2025 requires equal cost-sharing for oral and administered anticancer drugs.

The Cancer Drug Parity Act of 2025 amends the Employee Retirement Income Security Act of 1974 to mandate that group health plans provide cost-sharing for oral anticancer drugs on terms no less favorable than those for anticancer medications administered by a health care provider. This applies to medications prescribed for killing, slowing, or preventing the growth of cancerous cells. The Act prohibits plans from increasing out-of-pocket costs or applying more restrictive limitations on oral medications.